(Reuters) - Pfizer Inc. is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, The Wall Street Journal reported, citing people familiar with the matter.
An advisory committee for the FDA unanimously voted last week to support a nonprescription version of Narcan's nasal spray. But the list price could still pose a barrier.
SCOTUS refused to hear J&J's appeal regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.